Stocks
Health Care
acrs
Aclaris Therapeutics
NASDAQ: ACRS
+1.80 (+68.70%)
4.42
USD
At close at Jan 20, 21:40 UTC
Income Statement
Revenue
18.72M
Gross Profit
3.26M
Operating Income
-139.43M
Pretax Income
-141.68M
Net Income
-132.06M
EBITDA
-131.26M
EBIT
-132.06M
Earnings Per Share
-1.71
Balance Sheet
Cash & Cash Equivalents
32.72M
Total Debt
-
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
140.39M
Book Value Per Share
1.97
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.